More Than

0

customers

In

0

Key Cities

across

0

Countries in Southeast Asia

corporate video

Click to watch corporate video.

Latest news

news

Hyphens Pharma and A*STAR Ink MoU to be Strategic Dialogue Partners in the Field of Dermatology

Hyphens Pharma and Agency for Science, Technology and Research (A*STAR) inked a memorandum of understanding (MoU) on becoming strategic dialogue partners to explore collaboration in market-relevant projects in dermatology research and skin disorders.

Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR’s Institute of Chemical and Engineering Sciences (ICES). By leveraging A*STAR’s research and development capabilities, it is envisioned that this MoU will enable Hyphens to develop innovative and differentiated dermatological products to address unmet market needs.

Hyphens is a Singapore-headquartered ASEAN specialty pharma company. Operating in six countries across the region, Hyphens has a strong medical, regulatory and commercial capability. Dermatology is a key therapeutic focus field where Hyphens markets products under the brands “Ceradan” and “TDF”.

Read more Read less
news

22nd Regional Conference of Dermatology (RCD 2016), 21-24 April 2016 – Raffles City Convention Centre, Singapore

Hyphens took centre stage as the sole Diamond Supporter of this event which drew more than 1,000 delegates from around the region.

We successfully achieved full house for two of our supported symposiums delivered by key speakers from Germany and Singapore. The first symposium was on the advancement in atopic dermatitis and COPES, featuring our study in collaboration with KK Women’s and Children’s Hospital and National Skin Centre (Ceradan®). The second symposium was on urticaria and the clinical relevance of PAF (Rupafin®).

Read more Read less
View more
Go top